2023 Q4 Form 20-F Financial Statement

#000110465923118680 Filed on November 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q2 2023
Revenue $528.0K
YoY Change -126.6%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.397K
YoY Change 370.37%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$192.1K
YoY Change -93.29%
Income Tax $11.18K
% Of Pretax Income
Net Earnings -$409.3K
YoY Change -85.44%
Net Earnings / Revenue -77.51%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$0.02
COMMON SHARES
Basic Shares Outstanding 19.84M 19.84M
Diluted Shares Outstanding 19.84M

Balance Sheet

Concept 2023 Q4 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $114.8K
Short-Term Investments
Other Short-Term Assets $1.473M
YoY Change 140.75%
Inventory $197.2K
Prepaid Expenses
Receivables $401.4K
Other Receivables $253.6K
Total Short-Term Assets $2.038M
YoY Change 164.29%
LONG-TERM ASSETS
Property, Plant & Equipment $20.80K
YoY Change 456.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $20.80K
YoY Change -97.0%
TOTAL ASSETS
Total Short-Term Assets $2.038M
Total Long-Term Assets $20.80K
Total Assets $2.059M
YoY Change 40.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $234.8K
YoY Change 5960.27%
Accrued Expenses
YoY Change
Deferred Revenue $392.5K
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.506M
YoY Change -18.59%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.677M
YoY Change 44.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.506M
Total Long-Term Liabilities $3.677M
Total Liabilities $7.183M
YoY Change 4.78%
SHAREHOLDERS EQUITY
Retained Earnings -$198.8M
YoY Change -5.21%
Common Stock $1.984K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.308M
YoY Change
Total Liabilities & Shareholders Equity $2.059M
YoY Change 40.68%

Cashflow Statement

Concept 2023 Q4 2023 Q2 2023
OPERATING ACTIVITIES
Net Income -$409.3K
YoY Change -85.44%
Depreciation, Depletion And Amortization $1.397K
YoY Change 370.37%
Cash From Operating Activities $71.87K
YoY Change -65.43%
INVESTING ACTIVITIES
Capital Expenditures $19.44K
YoY Change 1395.15%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$19.44K
YoY Change -72.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -87.44K
YoY Change
NET CHANGE
Cash From Operating Activities 71.87K
Cash From Investing Activities -19.44K
Cash From Financing Activities -87.44K
Net Change In Cash -35.00K
YoY Change -125.54%
FREE CASH FLOW
Cash From Operating Activities $71.87K
Capital Expenditures $19.44K
Free Cash Flow $52.43K
YoY Change -74.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P0Y
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001640251
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19837642
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19837642
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19837642
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19837642
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2022Q2 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
71871
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations
-44735
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P0Y
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21526747
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-204074
CY2023 dei Entity Registrant Name
EntityRegistrantName
WINS Finance Holdings Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1F, Building 1B
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
No. 58 Jianguo Road, Chaoyang District
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Beijing
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
100024
CY2023 dei Entity Address Country
EntityAddressCountry
CN
CY2023 dei Security12g Title
Security12gTitle
Ordinary Shares, par value $0.0001 per share
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19837642
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Firm
AuditorFirmId
3487
CY2023 dei Auditor Name
AuditorName
Audit Alliance LLP
CY2023 dei Auditor Location
AuditorLocation
Singapore
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114809
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
159543
CY2023Q2 us-gaap Inventory Net
InventoryNet
197198
CY2022Q2 us-gaap Inventory Net
InventoryNet
0
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
253626
CY2022Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
0
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1472518
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
611645
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2038151
CY2022Q2 us-gaap Assets Current
AssetsCurrent
771188
CY2023Q2 us-gaap Direct Financing Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
0
CY2022Q2 us-gaap Direct Financing Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
688663
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20804
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3740
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
20804
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
692403
CY2023Q2 us-gaap Assets
Assets
2058955
CY2022Q2 us-gaap Assets
Assets
1463591
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3506348
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4307188
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3506348
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4307188
CY2023Q2 us-gaap Lease Deposit Liability
LeaseDepositLiability
1797532
CY2022Q2 us-gaap Lease Deposit Liability
LeaseDepositLiability
2084305
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3676514
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2548305
CY2023Q2 us-gaap Liabilities
Liabilities
7182862
CY2022Q2 us-gaap Liabilities
Liabilities
6855493
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19837642
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19837642
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1984
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1984
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
211962111
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
211934432
CY2023Q2 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
4687085
CY2022Q2 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
4687085
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-198838994
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-198429741
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23120642
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23474027
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-5308456
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5280267
CY2023Q2 us-gaap Minority Interest
MinorityInterest
184549
CY2022Q2 us-gaap Minority Interest
MinorityInterest
-111635
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5123907
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5391902
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2058955
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1463591
CY2023 us-gaap Direct Financing Lease Revenue
DirectFinancingLeaseRevenue
298310
CY2022 us-gaap Direct Financing Lease Revenue
DirectFinancingLeaseRevenue
242740
CY2021 us-gaap Direct Financing Lease Revenue
DirectFinancingLeaseRevenue
174306
CY2023 us-gaap Financing Interest Expense
FinancingInterestExpense
127488
CY2022 us-gaap Financing Interest Expense
FinancingInterestExpense
0
CY2021 us-gaap Financing Interest Expense
FinancingInterestExpense
11181
CY2023 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
584653
CY2022 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
2258060
CY2021 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
9495002
CY2023 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
-413831
CY2022 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
-2015320
CY2021 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
-9331877
CY2023 us-gaap Revenues
Revenues
527992
CY2022 us-gaap Revenues
Revenues
-1984638
CY2021 us-gaap Revenues
Revenues
-9331877
CY2023 wins Business Taxes And Surcharge
BusinessTaxesAndSurcharge
4786
CY2022 wins Business Taxes And Surcharge
BusinessTaxesAndSurcharge
231
CY2021 wins Business Taxes And Surcharge
BusinessTaxesAndSurcharge
476
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
297151
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
276546
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
920194
CY2023 wins Nonoperating Rental Expenses
NonoperatingRentalExpenses
79074
CY2022 wins Nonoperating Rental Expenses
NonoperatingRentalExpenses
76442
CY2021 wins Nonoperating Rental Expenses
NonoperatingRentalExpenses
97693
CY2023 us-gaap Other Noninterest Expense
OtherNoninterestExpense
339065
CY2022 us-gaap Other Noninterest Expense
OtherNoninterestExpense
524518
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
6136647
CY2023 us-gaap Noninterest Expense
NoninterestExpense
720076
CY2022 us-gaap Noninterest Expense
NoninterestExpense
877737
CY2021 us-gaap Noninterest Expense
NoninterestExpense
7155010
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-192084
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2862375
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16486887
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11175
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
738
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24590417
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-203259
CY2022 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-2863113
CY2021 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-41077304
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
205995
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-52019
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-409254
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2811094
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-41077304
CY2023 wins Other Comprehensive Income Foreign Currency Transaction And Translation Adjustments Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentsNetOfTaxPortionAttributableToParent
-357564
CY2022 wins Other Comprehensive Income Foreign Currency Transaction And Translation Adjustments Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentsNetOfTaxPortionAttributableToParent
-187029
CY2021 wins Other Comprehensive Income Foreign Currency Transaction And Translation Adjustments Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentsNetOfTaxPortionAttributableToParent
-2381422
CY2023 wins Comprehensive Income Losses Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeLossesNetOfTaxAttributableToNoncontrollingInterest
154305
CY2022 wins Comprehensive Income Losses Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeLossesNetOfTaxAttributableToNoncontrollingInterest
-2676084
CY2021 wins Comprehensive Income Losses Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeLossesNetOfTaxAttributableToNoncontrollingInterest
-38695882
CY2023 wins Other Comprehensive Income Losses Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossesNetOfTaxPortionAttributableToNoncontrollingInterest
-161935
CY2022 wins Other Comprehensive Income Losses Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossesNetOfTaxPortionAttributableToNoncontrollingInterest
48238
CY2021 wins Other Comprehensive Income Losses Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossesNetOfTaxPortionAttributableToNoncontrollingInterest
0
CY2023 wins Comprehensive Income Loss Net Of Tax
ComprehensiveIncomeLossNetOfTax
-7630
CY2022 wins Comprehensive Income Loss Net Of Tax
ComprehensiveIncomeLossNetOfTax
-2627846
CY2021 wins Comprehensive Income Loss Net Of Tax
ComprehensiveIncomeLossNetOfTax
-38695882
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19837642
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19837642
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19837642
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19837642
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19837642
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19837642
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.07
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.07
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.14
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.14
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.07
CY2021 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.07
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2022 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2021 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2652421
CY2022 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
63397
CY2022 wins Net Income Loss Net Of Statutory Reserve
NetIncomeLossNetOfStatutoryReserve
-2863113
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
187029
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5391902
CY2023 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
86010
CY2023 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
27679
CY2023 wins Net Income Loss Net Of Statutory Reserve
NetIncomeLossNetOfStatutoryReserve
-203259
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
357564
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5123907
CY2023 us-gaap Profit Loss
ProfitLoss
-203259
CY2022 us-gaap Profit Loss
ProfitLoss
-2863113
CY2021 us-gaap Profit Loss
ProfitLoss
-41077304
CY2023 us-gaap Depreciation
Depreciation
1397
CY2022 us-gaap Depreciation
Depreciation
297
CY2021 us-gaap Depreciation
Depreciation
838
CY2023 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
0
CY2022 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
0
CY2021 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
24718
CY2023 wins Provision For Loan Lease Payment Receivables
ProvisionForLoanLeasePaymentReceivables
56291
CY2022 wins Provision For Loan Lease Payment Receivables
ProvisionForLoanLeasePaymentReceivables
2258060
CY2021 wins Provision For Loan Lease Payment Receivables
ProvisionForLoanLeasePaymentReceivables
9495002
CY2023 wins Provision For Other Assets
ProvisionForOtherAssets
0
CY2022 wins Provision For Other Assets
ProvisionForOtherAssets
0
CY2021 wins Provision For Other Assets
ProvisionForOtherAssets
3017816
CY2023 wins Acquisition Of Additional Interests In Subsidiaries
AcquisitionOfAdditionalInterestsInSubsidiaries
116785
CY2022 wins Acquisition Of Additional Interests In Subsidiaries
AcquisitionOfAdditionalInterestsInSubsidiaries
0
CY2021 wins Acquisition Of Additional Interests In Subsidiaries
AcquisitionOfAdditionalInterestsInSubsidiaries
0
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
26108436
CY2023 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
-609547
CY2022 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
194077
CY2021 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
-5887016
CY2023 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
941464
CY2022 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-186571
CY2021 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
628927
CY2023 wins Lease Receivable In Lease Agency Transaction
LeaseReceivableInLeaseAgencyTransaction
0
CY2022 wins Lease Receivable In Lease Agency Transaction
LeaseReceivableInLeaseAgencyTransaction
0
CY2021 wins Lease Receivable In Lease Agency Transaction
LeaseReceivableInLeaseAgencyTransaction
-2085456
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
205276
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-8874
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1518019
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1296367
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0
CY2023 wins Increase Decrease In Deposits From Financing Lease
IncreaseDecreaseInDepositsFromFinancingLease
-236406
CY2022 wins Increase Decrease In Deposits From Financing Lease
IncreaseDecreaseInDepositsFromFinancingLease
115404
CY2021 wins Increase Decrease In Deposits From Financing Lease
IncreaseDecreaseInDepositsFromFinancingLease
-3649836
CY2023 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-422111
CY2022 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
704781
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
250671
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
207923
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13007
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19437
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1300
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2023 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
CY2022 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
69594
CY2021 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-19437
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70894
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
264014
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
CY2023 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
176576
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-87438
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9731
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6116
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2817
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
0
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
0
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
-7553701
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations
130913
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations
-10190
CY2023 wins Cash Provided By Used In Discontinued Operations
CashProvidedByUsedInDiscontinuedOperations
0
CY2022 wins Cash Provided By Used In Discontinued Operations
CashProvidedByUsedInDiscontinuedOperations
0
CY2021 wins Cash Provided By Used In Discontinued Operations
CashProvidedByUsedInDiscontinuedOperations
-7553701
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159543
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28630
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38820
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
0
CY2021Q2 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
0
CY2020Q2 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
7553701
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114809
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
159543
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28630
CY2023Q2 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
0
CY2022Q2 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
0
CY2021Q2 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
0
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0
CY2021 us-gaap Interest Paid Net
InterestPaidNet
11181
CY2023 wins Additional Information Of Acquisition Of Additional Interests In Subsidiaries
AdditionalInformationOfAcquisitionOfAdditionalInterestsInSubsidiaries
116785
CY2022 wins Additional Information Of Acquisition Of Additional Interests In Subsidiaries
AdditionalInformationOfAcquisitionOfAdditionalInterestsInSubsidiaries
0
CY2021 wins Additional Information Of Acquisition Of Additional Interests In Subsidiaries
AdditionalInformationOfAcquisitionOfAdditionalInterestsInSubsidiaries
0
CY2016Q2 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
270000
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-203259
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-5308456
CY2023Q2 wins Net Current Assets Liabilities
NetCurrentAssetsLiabilities
-1468197
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:8pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 10pt 0pt;"><b style="font-size:10pt;font-weight:bold;">(b)</b><b style="font-weight:bold;">   </b><b style="font-size:10pt;font-weight:bold;">Use of estimates</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 18pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. On an ongoing basis, management reviews these estimates using information that are currently available. Changes in facts and circumstances may cause Wins Finance to revise its estimates. Material estimates that are particularly susceptible to significant change in the near-term include the determination of the allowances for doubtful accounts receivable, inventory reserve provision and for guarantee losses.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 18pt;">Significant accounting estimates reflected in the financial statements include, but are not limited to: (i) the allowance for doubtful receivables; (ii) estimates of losses on unexpired contracts and financial guarantee service contracts; (iii) accrual of estimated liabilities; (iv) useful lives of long-lived assets; (v) impairment of long-lived assets; (vi) valuation allowance for deferred tax assets; (vii) contingencies; and (viii) share-based compensation; (viiii) inventory reserve provision.</p>
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2022Q2 us-gaap Deposit Liabilities Reclassified As Loans Receivable1
DepositLiabilitiesReclassifiedAsLoansReceivable1
32822
CY2023Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
274129
CY2022Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
273758
CY2023Q2 us-gaap Other Receivables
OtherReceivables
32090
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Property Plant And Equipment Salvage Value Percentage
PropertyPlantAndEquipmentSalvageValuePercentage
0.03
CY2022Q2 us-gaap Other Receivables
OtherReceivables
43213
CY2023Q2 us-gaap Other Assets
OtherAssets
1472518
CY2022Q2 us-gaap Other Assets
OtherAssets
611645
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q2 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
7.2258
CY2022Q2 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
6.7114
CY2023 wins Foreign Currency Exchange Rate Translation Income Statement
ForeignCurrencyExchangeRateTranslationIncomeStatement
6.9415
CY2022 wins Foreign Currency Exchange Rate Translation Income Statement
ForeignCurrencyExchangeRateTranslationIncomeStatement
6.4571
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1270000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12
CY2023 us-gaap Revenue Recognition Leases
RevenueRecognitionLeases
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">(r)   Operating leases</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 18pt;">The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current and non-current lease liabilities on the Company’s consolidated statement of financial position. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 18pt;">ROU lease assets represent the Company’s right to use an underlying asset for the lease term and lease obligations represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most of the Company’s leases do not provide an implicit rate, the Company use its incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The Company’s incremental borrowing rate for a lease is the rate of interest it would have to pay to borrow an amount equal to the lease payments under similar terms. The operating lease ROU assets also include initial direct costs incurred and any lease payments made to the lessor or before the commencement date, minus any lease incentives received. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term.</p>
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y5M1D
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12
CY2022Q2 wins Allowance For Doubtful Accounts Advances To Suppliers
AllowanceForDoubtfulAccountsAdvancesToSuppliers
0
CY2023Q2 wins Allowance For Doubtful Accounts Advances To Suppliers
AllowanceForDoubtfulAccountsAdvancesToSuppliers
0
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12
CY2018 wins Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Remaining Contractual Term2 Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageRemainingContractualTerm2Granted
P3Y
CY2020 wins Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Remaining Contractual Term2 Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageRemainingContractualTerm2Granted
P3Y
CY2021 wins Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Remaining Contractual Term2 Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageRemainingContractualTerm2Granted
P3Y
CY2017 wins Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Remaining Contractual Term2 Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageRemainingContractualTerm2Granted
P3Y
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
113888592
CY2022Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
122893158
CY2023Q2 wins Lessee Finance Lease Variable Lease Payment Terms And Condition
LesseeFinanceLeaseVariableLeasePaymentTermsAndCondition
0
CY2022Q2 wins Lessee Finance Lease Variable Lease Payment Terms And Condition
LesseeFinanceLeaseVariableLeasePaymentTermsAndCondition
0
CY2023Q2 wins Minimum Lease Payment Sale Leaseback Transactions
MinimumLeasePaymentSaleLeasebackTransactions
113888592
CY2022Q2 wins Minimum Lease Payment Sale Leaseback Transactions
MinimumLeasePaymentSaleLeasebackTransactions
122893158
CY2023Q2 wins Direct Financing Lease Net Investment In Lease Accrued Interest Before Allowance For Credit Loss
DirectFinancingLeaseNetInvestmentInLeaseAccruedInterestBeforeAllowanceForCreditLoss
3243488
CY2022Q2 wins Direct Financing Lease Net Investment In Lease Accrued Interest Before Allowance For Credit Loss
DirectFinancingLeaseNetInvestmentInLeaseAccruedInterestBeforeAllowanceForCreditLoss
3137139
CY2023Q2 us-gaap Direct Financing Lease Net Investment In Lease Before Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseBeforeAllowanceForCreditLossNoncurrent
110645104
CY2022Q2 us-gaap Direct Financing Lease Net Investment In Lease Before Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseBeforeAllowanceForCreditLossNoncurrent
119756019
CY2023Q2 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossNoncurrent
110645104
CY2022Q2 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossNoncurrent
119067356
CY2023Q2 us-gaap Direct Financing Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
0
CY2022Q2 us-gaap Direct Financing Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
688663
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
6030
CY2022Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
332802
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
0
CY2022Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
41764
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
38797
CY2022Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
101782289
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
96582534
CY2022Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
14659311
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Five Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears
11900382
CY2022Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Five Years
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears
6076992
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Thereafter
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter
5360850
CY2022Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Thereafter
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter
0
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
113888592
CY2022Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
122893158
CY2023Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
110645104
CY2022Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
119067356
CY2019 wins Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Remaining Contractual Term2 Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageRemainingContractualTerm2Granted
P3Y
CY2022 wins Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Weighted Average Remaining Contractual Term2 Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingWeightedAverageRemainingContractualTerm2Granted
P3Y
CY2023Q2 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossNoncurrent
110645104
CY2022Q2 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossNoncurrent
119067356
CY2022Q2 us-gaap Direct Financing Lease Net Investment In Lease After Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAfterAllowanceForCreditLossNoncurrent
688663
CY2022Q2 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossNoncurrent
119067356
CY2021Q2 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossNoncurrent
121442109
CY2023 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-1755062
CY2022 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-25971
CY2023 wins Provision For Lease Payment Receivables
ProvisionForLeasePaymentReceivables
0
CY2022 wins Provision For Lease Payment Receivables
ProvisionForLeasePaymentReceivables
2284032
CY2023 us-gaap Translation Adjustment Functional To Reporting Currency Tax Expense Benefit
TranslationAdjustmentFunctionalToReportingCurrencyTaxExpenseBenefit
6667190
CY2022 us-gaap Translation Adjustment Functional To Reporting Currency Tax Expense Benefit
TranslationAdjustmentFunctionalToReportingCurrencyTaxExpenseBenefit
4632814
CY2023Q2 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossNoncurrent
110645104
CY2022Q2 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossNoncurrent
119067356
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
110645104
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
119064028
CY2022Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
3328
CY2023Q2 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossNoncurrent
110645104
CY2022Q2 us-gaap Direct Financing Lease Net Investment In Lease Allowance For Credit Loss Noncurrent
DirectFinancingLeaseNetInvestmentInLeaseAllowanceForCreditLossNoncurrent
119067356
CY2023Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
110645104
CY2022Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
119064028
CY2023Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3243488
CY2022Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
3829130
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
113888592
CY2022Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
122893158
CY2023Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
113888592
CY2022Q2 us-gaap Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received
SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
122893158
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
213879
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
224152
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20804
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3740
CY2023 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
1397
CY2022 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
297
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
401399
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
261852
CY2023Q2 wins Advance To Suppliers Current
AdvanceToSuppliersCurrent
290260
CY2023Q2 us-gaap Deposit Liabilities Reclassified As Loans Receivable1
DepositLiabilitiesReclassifiedAsLoansReceivable1
474640
CY2023Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1535202
CY2022Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1630159
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
234775
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3874
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
392549
CY2023Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
149761
CY2022Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
172508
CY2022Q2 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
1260000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
321430
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
381224
CY2023Q2 us-gaap Loans Payable Current
LoansPayableCurrent
58660
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
263205
CY2023Q2 wins Accrued Audit Fees Current
AccruedAuditFeesCurrent
50000
CY2022Q2 wins Accrued Audit Fees Current
AccruedAuditFeesCurrent
60000
CY2023Q2 wins Rental And Property Management Fee Payable
RentalAndPropertyManagementFeePayable
245846
CY2022Q2 wins Rental And Property Management Fee Payable
RentalAndPropertyManagementFeePayable
264689
CY2023Q2 wins Deposit Payable For Goods Current
DepositPayableForGoodsCurrent
421905
CY2023Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
96220
CY2022Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
271529
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3506348
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4307188
CY2015Q4 wins Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentage
0.10
CY2015Q4 wins Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedPercentage
0.10
CY2015Q4 wins Share Based Compensation Arrangement By Share Based Payment Award Exercise Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePeriod
P10Y
CY2015Q4 wins Share Based Compensation Arrangement By Share Based Payment Award Grant Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantPeriod
P10Y
CY2015Q4 wins Share Based Compensation Arrangement By Share Based Payment Award Grant Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantPeriod
P10Y
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1190000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1190000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1190000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1190000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1190000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1190000
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
80000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
80000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
80000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
80000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
80000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
80000
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1190000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
80000
CY2017Q1 wins Consideration For Option Agreements Terminated
ConsiderationForOptionAgreementsTerminated
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.515
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0177
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016Q2 us-gaap Share Price
SharePrice
2.80
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21526747
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19837642
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19837642
CY2023 wins Percentage Allocation Of Annual After Tax Profit To General Reserves
PercentageAllocationOfAnnualAfterTaxProfitToGeneralReserves
10
CY2023 wins Limit Of General Reserve To Distribute Dividends
LimitOfGeneralReserveToDistributeDividends
0.50
CY2023 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
32239
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
89501
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-409254
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2811094
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19837642
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19837642
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19837642
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19837642
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2023Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
11175
CY2022Q2 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
738
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
11175
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
738
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11175
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
738
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2023 wins Effective Income Tax Rate Reconciliation Preferential Tax Rate
EffectiveIncomeTaxRateReconciliationPreferentialTaxRate
-0.215
CY2022 wins Effective Income Tax Rate Reconciliation Preferential Tax Rate
EffectiveIncomeTaxRateReconciliationPreferentialTaxRate
-0.225
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.035
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.025
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
253626
CY2023Q2 us-gaap Lease Deposit Liability
LeaseDepositLiability
1797532
CY2022Q2 us-gaap Lease Deposit Liability
LeaseDepositLiability
2084305
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
41988
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7958
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
49946
CY2022Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
1
CY2020Q3 wins Repayment Of Loan Being Highly Uncertain Amount Of Loan
RepaymentOfLoanBeingHighlyUncertainAmountOfLoan
580000000

Files In Submission

Name View Source Status
0001104659-23-118680-index-headers.html Edgar Link pending
0001104659-23-118680-index.html Edgar Link pending
0001104659-23-118680.txt Edgar Link pending
0001104659-23-118680-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wins-20230630.xsd Edgar Link pending
wins-20230630x20f.htm Edgar Link pending
wins-20230630x20f001.jpg Edgar Link pending
wins-20230630x20f005.jpg Edgar Link pending
wins-20230630x20f006.jpg Edgar Link pending
wins-20230630xex12d1.htm Edgar Link pending
wins-20230630xex12d2.htm Edgar Link pending
wins-20230630xex13d1.htm Edgar Link pending
wins-20230630xex16d1.htm Edgar Link pending
wins-20230630xex8d1.htm Edgar Link pending
wins-20230630_lab.xml Edgar Link unprocessable
wins-20230630_cal.xml Edgar Link unprocessable
wins-20230630_def.xml Edgar Link unprocessable
wins-20230630_pre.xml Edgar Link unprocessable
wins-20230630x20f_htm.xml Edgar Link completed